EUVIMEDOpdag EUVIMED
Crossref

The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway

Anna Han, Taorui Liu, Pan Du, Mengying Wang, Jiajing Liu, Liyan Chen

Molecular Carcinogenesis · 2024

DOI: 10.1002/mc.23681 ↗

At a glance

Journal article in Molecular Carcinogenesis, 2024. Written by Anna Han and 5 co-authors. Institution: Key Laboratory Pathobiology (Yanbian University), State Ethnic Affairs Commission, Yanji, China. Major MEDLINE topics: Stomach Neoplasms. Cited 4 times so far (Crossref); 25 references. Funded by: National Natural Science Foundation of China, Projects of Science and Technology Department of Jilin Province.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Gastric cancer (GC) is a prevalent malignancy of the digestive system. Distant metastasis and chemotherapy resistance are the crucial obstacles to prognosis in GC. Recent research has discovered that the glucose‐6‐phosphatase catalytic subunit (G6PC) plays an important role in tumor malignant development. However, little evidence has highlighted its role in GC. Herein, through a comprehensive analysis including profiling of tissue samples and functional validation in vivo and in vitro, we identify G6PC as a crucial factor in GC tumorigenesis. Importantly, we found that the FOXO1/G6PC axis could accelerate GC cell proliferation, metastasis, and 5‐Fluorouracil (5‐FU) resistance by targeting the PI3K/AKT/mTOR signaling pathway, implicating that as a prospective therapeutic approach in GC.

Subjects

MeSH terms (MEDLINE)

Stomach NeoplasmsHumansProto-Oncogene Proteins c-aktFluorouracilPhosphatidylinositol 3-KinasesSignal TransductionTOR Serine-Threonine KinasesCell Line, TumorCell ProliferationForkhead Box Protein O1

Author keywords

5-FU resistanceFOXO1G6PCGastric cancerPI3K/AKT/mTORProgression

Substances

Proto-Oncogene Proteins c-aktFluorouracilPhosphatidylinositol 3-KinasesTOR Serine-Threonine KinasesFOXO1 protein, humanForkhead Box Protein O1

Authors and institutions

  • Key Laboratory Pathobiology (Yanbian University), State Ethnic Affairs Commission, Yanji, China.
  • Center for Joint Surgery, Southwest Hospital, Army Medical University, Chongqing, China.
  • Cancer Research Center, Yanbian University Medical College, Yanji, China.

Funding

  • National Natural Science Foundation of China
  • Projects of Science and Technology Department of Jilin Province

Cite

APA

Han, A., Liu, T., Du, P., Wang, M., Liu, J., & Chen, L. (2024). The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23681

Vancouver

Han A, Liu T, Du P, Wang M, Liu J, Chen L. The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23681

BibTeX
@article{Han2024,
  author = {Han, Anna and Liu, Taorui and Du, Pan and Wang, Mengying and Liu, Jiajing and Chen, Liyan},
  title = {The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway},
  journal = {Molecular Carcinogenesis},
  year = {2024},
  doi = {10.1002/mc.23681}
}
Start for free →